Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study. Reumatismo [Internet]. 2014 Nov. 6 [cited 2025 Apr. 26];66(3):224-32. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2014.748